Cardiovascular

FDA permits marking of hand-held scanner for detecting intracranial hematomas

On Dec. 13, the U.S. Food and Drug Administration (FDA) announced it was allowing marketing of the first hand-held device for detecting intracranial hematomas, using near-infrared spectroscopy. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Newsletter Subscribe

  • This field is for validation purposes and should be left unchanged.

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing

Shares